Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

In just four days, General Motors fast-tracked a plan to help a stretched medical device company build 200,000 badly needed ventilators to treat coronavirus patients.

Why it matters: It's not only a symbol of GM's significant industrial might 11 years after a government-brokered bankruptcy. It also shows how President Trump is squeezing American businesses to act.

  • Instead of invoking the Defense Production Act to marshal private resources for the federal government, Trump has been pushing the nation’s biggest manufacturers to come up with enterprising solutions on their own.

What's happening: GM worked "around the clock" over the weekend to secure suppliers for the parts needed to help Ventec Life Systems dramatically boost ventilator output, the automaker said Monday.

  • GM is even studying the feasibility of building Ventec ventilators at its Kokomo, Indiana, plant, which made vehicle electronics until last week, when the automaker suspended North American production due to the outbreak.
  • UAW workers have been notified of the potential restart, and an announcement could come Tuesday, said people familiar with the plans.
  • The goal of the partnership is to build up to 200,000 ventilators, Reuters reported.

Yes, but: A company can't build a car — or a ventilator — unless it has all the parts.

  • GM has lined up suppliers for 95% of the necessary components and is seeking to source the remaining 37 parts, according to an email to suppliers from Shilpan Amin, GM's vice president of global purchasing, per Reuters.
  • Production could start within a week, suppliers told Crain's Detroit Business.
  • "We're off and running. The tool shops are designing tools right now," Eric Showalter, CEO of Myotek North America, told Crain's. "We're able to at least start to kick off tools in China to build these things. If we get paid, we get paid. We're all just trying to help where we can."

Flashback: CEO Mary Barra offered GM's help in a phone call with White House Economic Advisor Larry Kudlow on March 18.

  • By Friday, GM's top manufacturing brass was visiting Ventec's manufacturing facility in suburban Seattle to learn what was needed.
  • On Sunday afternoon, Trump tweeted: "Ford, General Motors and Tesla are being given the go ahead to make ventilators and other metal products, FAST!"
  • By Sunday evening, Amin informed Barra that GM and Ventec had secured supplier commitments for nearly all of the 600-plus parts needed to produce Ventec's innovative multi-function ventilators.
  • Early Monday, the FDA temporarily relaxed certain policy guidelines, a critical step to allow manufacturers to rapidly expand production.

Between the lines: Trump publicly pushed GM to move heroically, but if the effort fails, it will be GM left facing the fallout.

The bottom line: It would be a monumental feat if GM pulls it off in less than a week. "We know that time is not on our side," said GM spokesman Dan Flores.

Go deeper

Schumer proposes federal decriminalization of marijuana

Schumer at the NYC Cannabis Parade & Rally in March. Photo: Angela Weiss/AFP via Getty Images

Senate Majority Leader Chuck Schumer (D-N.Y.), Sen. Cory Booker (D-N.J.) and Sen. Ron Wyden (D-Ore.) unveiled draft legislation on Wednesday to decriminalize marijuana at the federal level.

Why it matters: Though the legislation faces steep odds in the 50-50 Senate, it's a major milestone for marijuana activists and a sign of how far the debate has moved on criminal justice and the war on drugs.

24 mins ago - World

U.S. prepared to lift nearly all Iran sanctions, Zarif tells parliament

Zarif on a visit to Moscow. Photo: Russian Foreign Ministry handout via Getty

Outgoing Iranian Foreign Minister Mohammad Javad Zarif wrote in a report to parliament that the Biden administration has agreed to lift almost all U.S. sanctions on Iran to secure a mutual return to the 2015 nuclear deal.

Why it matters: The report includes details that hadn't been made public before now and is the most official and comprehensive Iranian account of the status of the indirect talks with the U.S.

2 hours ago - Health

CDC says drug overdose deaths hit record 93,300 in 2020

Roy Lee stands next to his girlfriend Trina Mills' as she holds a photograph of her son Shane Robert Mills while attending Black Balloon Day, a day to honor those who have died due to accidental overdoses on March 6, 2021. Photo: Erin Clark/The Boston Globe via Getty Images

Deaths from drug overdoses in the U.S. soared by nearly 30% in 2020, reaching a record high of 93,331, according to provisional data released Wednesday by the Centers for Disease Control and Prevention.

Why it matters: The shocking figures — which represent the sharpest annual increase in at least three decades — reflect the proliferation of the synthetic opioid fentanyl in the illegal narcotic supply and the pandemic's toll on the opioid crisis.